神经丝轻链(NfL)水平作为缺血性卒中后长期预后的预测标志物
结果显示sNfL与入院NIHSS评分相关,可预测90天不良功能结局(mRS≥2)及36个月内复合心血管终点事件。
要点
- sNfL与入院NIHSS评分显著相关(r=0.234;P<0.001)。
- sNfL可预测90天不良功能结局(OR 1.562;95%CI 1.003-2.433;P=0.048)。
- sNfL可预测36个月复合心血管终点事件(OR 2.002;95%CI 1.213-3.302;P=0.007)。
核心结论
- sNfL是缺血性卒中后90天功能独立性的有价值生物标志物,并能预测长期心血管结局。
主要发现
- sNfL与入院NIHSS评分显著相关(r=0.234;P<0.001)。
- sNfL水平随年龄相关白质改变等级增加而升高(P<0.001)。
- 多因素回归分析显示sNfL预测90天不良功能结局(mRS≥2)的OR为1.562(95%CI 1.003-2.433;P=0.048),NIHSS的OR为1.303(95%CI 1.164-1.458;P<0.001),严重年龄相关白质改变的OR为3.326(95%CI 1.186-9.326;P=0.022)。
- sNfL预测复合心血管终点事件的OR为2.002(95%CI 1.213-3.302;P=0.007),NIHSS的OR为1.110(95%CI 1.000-1.232;P=0.049),糖尿病的OR为2.942(95%CI 1.306-6.630;P=0.005),严重年龄相关白质改变的OR为4.816(95%CI 1.206-19.229;P=0.026)。
- Kaplan-Meier分析显示sNfL升高组复合心血管终点事件显著增多(18[14.1%] vs 38[45.8%],log-rank P<0.001)。
临床怎么用
- sNfL或可作为缺血性卒中后功能结局和长期心血管风险的辅助预测指标,帮助个体化治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Ischemic stroke causes major disability as a consequence of neuronal loss and recurrent ischemic events. Biomarkers predicting tissue damage or stroke recurrence might be useful to guide an individualized stroke therapy. NfL (neurofilament light chain) is a promising biomarker that might be used for this purpose. Methods- We used individual data of patients with an acute ischemic stroke and clinical long term follow-up. Serum NfL (sNfL) was quantified within 24 hours after admission and after 1 year and compared with other biomarkers (GDF15 [growth differentiation factor 15], S100, NT-proBNP [N-terminal pro-B-type natriuretic peptide], ANP [atrial natriuretic peptide], and FABP [fatty acid-binding protein]). The primary end point was functional outcome after 90 days and cerebrovascular events and death (combined cardiovascular end point) within 36 months of follow-up. Results- Two hundred eleven patients (mean age, 68.7 years; SD, ±12.6; 41.2% women) with median clinical severity on the National Institutes of Health Stroke Scale (NIHSS) score of 3 (interquartile range, 1-5) and long-term follow-up with a median of 41.8 months (interquartile range, 40.0-44.5) were prospectively included. We observed a significant correlation between sNfL and NIHSS at hospital admission (r=0.234; P<0.001). sNfL levels increased with the grade of age-related white matter changes (P<0.001) and were able to predict unfavorable clinical outcome (modified Rankin Scale score, ≥2) 90 days after stroke (odds ratio [OR], 1.562; 95% CI, 1.003-2.433; P=0.048) together with NIHSS (OR, 1.303; 95% CI, 1.164-1.458; P<0.001) and age-related white matter change rating (severe; OR, 3.326; 95% CI, 1.186-9.326; P=0.022). Similarly, sNfL was valuable for the prediction of the combined cardiovascular end point (OR, 2.002; 95% CI, 1.213-3.302; P=0.007), besides NIHSS (OR, 1.110; 95% CI, 1.000-1.232; P=0.049), diabetes mellitus (OR, 2.942; 95% CI, 1.306-6.630; P=0.005), and age-related white matter change rating (severe; OR, 4.816; 95% CI, 1.206-19.229; P=0.026) after multivariate regression analysis. Kaplan-Meier analysis revealed significantly more combined cardiovascular end points (18 [14.1%] versus 38 [45.8%], log-rank test P<0.001) during long-term follow-up in patients with elevated sNfL levels. Conclusions- sNFL is a valuable biomarker for functional independence 90 days after ischemic stroke and predicts cardiovascular long-term outcome. Clinical Trial Registration- URL: http://www.isrctn.com. Unique identifier: ISRCTN 46104198.
引用
- Uphaus T, Bittner S, Gröschel S, et al. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke. Stroke. 2019. PMID: 31537188. doi:10.1161/STROKEAHA.119.026410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。